New User Account Set Up

If you do not have an account with the Digest, please click on "Submit to the Digest." By logging in with your UCLA Login ID (formerly known as BOL Login), a new account will automatically be generated. If you experience any difficulties, please send an email to our help desk:


If you have any questions or concerns, please email our help desk/support team: We are more than happy to address any questions or concerns regarding the Weekly Message Digest system you may have.

How do I subscribe?

If you have a mednet email account (, you should already be subscribed.

If you do not have a mednet email account or you are not receiving the Digest, please send an email to and we will add you to our list.

New in Online CME: Management of Neuroendocrine Tumors (NETs) & Zollinger Ellison Syndrome (ZES)

Management of Neuroendocrine Tumors (NETs) & Zollinger Ellison Syndrome (ZES)


Neuroendocrine tumors are often diagnosed late due to lack of specific symptoms during the early stages of the disease. Dr. Joseph Pisegna reviews the diagnosis and management of pancreatic neuroendocrine tumors, carcinoid tumors, and Zollinger-Ellison syndrome.


Joseph Pisegna, MD
Professor of Medicine and Human Genetics
David Geffen School of Medicine at UCLA
Chief, Division of Gastroenterology, Hepatology and Parenteral Nutrition
Department of Veterans Affairs, VAGLAHS


At the conclusion of this activity, participants should be able to:

  • Demonstrate understanding of pathophysiology of neuroendocrine tumors
  • Direct a multi-disciplinary approach with patients with neuroendocrine tumors
  • Order appropriate tests to evaluate for neuroendocrine tumors


Posting Information
This posting expired on August 06, 2018.

Share this posting on social media!